The Efficacy of Telemedicine Rehabilitation Programs In Regard Of Risk Factors Control In Patients With Paroxysmal Atrial Fibrillation Aftercatheter Ablation

Aim      To evaluate changes in traditional risk factors (RF) during cardiac rehabilitation (CR) programs with remote support in patients with paroxysmal atrial fibrillation (AF) after catheter ablation (CA).

Material and methods  The lack of control of cardiovascular RFs is a predictor for AF recurrence after CA, development of complications, and decreased life expectancy. Telemedical CR programs may improve the control of RF and enhance the CR efficacy. This randomized controlled clinical study in three parallel groups included 135 patients aged 35 to 79 years. In groups 1 and 2, CR programs with remote support were performed, which included a single personal consulting for the disease, achieving control of all patient’s RFs, and remote support during 3 months (group 1, by phone and group 2, by e-mail). Participants of group 3 received standard recommendations. Body weight, blood pressure (BP), blood lipids, smoking status, and physical activity (PA) were determined at baseline and at 12 months after CA with the IPAQ questionnaire.

Results In both intervention groups at 12 months, there were positive changes in RF: body weight index decreased by 3.6 % in group 1 (р=0.01) and by 2.3 % in group 2 (р=0.002) vs. 0 in the control group; systolic BP decreased by 7.1 % (p<0.001) and 1.5 % (p=0.003) in groups 1 and 2 (vs. increases by 3.3 % in group 2); total cholesterol decreased by 9.4 % (p<0.001) and by 6.3 % (p=0.003), respectively, (vs. 0 in group 3); values of metabolic equivalents (METs) used for walking increased by 55.0 % (р=0.014), 75.0 % (р=0.001), and 1.4 % in groups 1, 2 and 3, respectively. No significant intergroup differences in the frequency of AF recurrence, repeated CA, and hospitalizations were found.

Conclusion      CR programs with remote support provide improved control of BP, body weight, blood cholesterol, and AF in patients with AF after CA, according to the results of the one-year follow-up.

1. Ferrari R, Bertini M, Blomstrom-Lundqvist C, Dobrev D, Kirchhof P, Pappone C et al. An update on atrial fibrillation in 2014: From pathophysiology to treatment. International Journal of Cardiology. 2016;203:22–9. DOI: 10.1016/j.ijcard.2015.10.089

2. Friberg L, Rosenqvist M, Lindgren A, Terent A, Norrving B, Asplund K. High Prevalence of Atrial Fibrillation Among Patients With Ischemic Stroke. Stroke. 2014;45(9):2599–605. DOI: 10.1161/STROKEAHA.114.006070

3. Lau DH, Nattel S, Kalman JM, Sanders P. Modifiable Risk Factors and Atrial Fibrillation. Circulation. 2017;136(6):583–96. DOI: 10.1161/CIRCULATIONAHA.116.023163

4. Stabile G, Bertaglia E, Senatore G, Simone AD, Zerbo F, Carreras G et al. Feasibility of Pulmonary Vein Ostia Radiofrequency Ablation in Patients with Atrial Fibrillation: A Multicenter Study (CACAF Pilot Study). Pacing and Clinical Electrophysiology. 2003;26(1P2):284–7. DOI: 10.1046/j.1460-9592.2003.00033.x

5. Rottner L, Bellmann B, Lin T, Reissmann B, Tonnis T, Schleberger R et al. Catheter Ablation of Atrial Fibrillation: State of the Art and Future Perspectives. Cardiology and Therapy. 2020;9(1):45–58. DOI: 10.1007/s40119-019-00158-2

6. Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al. 2020 ESC Guidelines for the diagnosis and manage ment of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. European Heart Journal. 2020;42(5):373–498. DOI: 10.1093/eurheartj/ehaa612

7. Keteyian SJ, Ehrman JK, Fuller B, Pack QR. Exercise Testing and Exercise Rehabilitation for Patients With Atrial Fibrillation. Journal of Cardiopulmonary Rehabilitation and Prevention. 2019;39(2):65–72. DOI: 10.1097/HCR.0000000000000423

8. Younis A, Shaviv E, Nof E, Israel A, Berkovitch A, Goldenberg I et al. The role and outcome of cardiac rehabilitation program in patients with atrial fibrillation. Clinical Cardiology. 2018;41(9):1170–6. DOI: 10.1002/clc.23001

9. Lin JS, O’Connor EA, Evans CV, Senger CA, Rowland MG, Groom HC. Behavioral Counseling to Promote a Healthy Lifestyle for Cardiovascular Disease Prevention in Persons With Cardiovascular Risk Factors: An Updated Systematic Evidence Review for the U.S. Preventive Services Task Force. Report No.: 13-05179-EF-1. PMID: 25232633. -Rockville (MD): Agency for Healthcare Research and Quality (US);2014.

10. Umpierre D. Physical Activity Advice Only or Structured Exercise Training and Association With HbA 1c Levels in Type 2 Diabetes: A Systematic Review and Meta-analysis. JAMA. 2011;305(17):1790– 9. DOI: 10.1001/jama.2011.576

11. Boytsov S.A., Pogosova N.V., Bubnova M.G., Drapkina O.M., Gavrilova N.E., Yeganyan R.A. et al. Cardiovascular prevention 2017. National guidelines. Russian Journal of Cardiology. 2018;23(6):7–122. DOI: 10.15829/1560-4071-2018-6-7-122

12. Varnfield M, Karunanithi M, Lee C-K, Honeyman E, Arnold D, Ding H et al. Smartphone-based home care model improved use of cardiac rehabilitation in postmyocardial infarction patients: results from a randomised controlled trial. Heart (British Cardiac Society). 2014;100(22):1770–9. DOI: 10.1136/heartjnl-2014-305783

13. Pogosova N.V., Badtieva V.A., Ovchinnikova A.I., Sokolova O.Yu., Vorobyeva N.M. Efficacy of secondary prevention and rehabilitation programs with distant support in patients with atrial fibrillation after intervention procedures: impact on psychological status. Kardiologiia. 2022;62(9):27–36. DOI: 10.18087/cardio.2022.9.n1951

14. Cheng Hoi Lun (Helen). A simple, easy-to-use spreadsheet for automatic scoring of the International Physical Activity Questionnaire (IPAQ) Short Form. DOI: 10.13140/RG.2.2.21067.80165. Av. at: http://rgdoi.net/10.13140/RG.2.2.21067.80165.2016.

15. Sjostrom M, Ainsworth BE, Bauman A, Bull FC, Hamilton-Craig C, Sallis J. Guidelines for data processing analysis of the International Physical Activity Questionnaire (IPAQ)-short and long forms. 2005. [Internet] 2005. Available at: https://www.scienceopen.com/document?vid=b223350f-d159-4043-9b48-e2031f210a3c

16. Pathak RK, Middeldorp ME, Lau DH, Mehta AB, Mahajan R, Twomey D et al. Aggressive Risk Factor Reduction Study for Atrial Fibrillation and Implications for the Outcome of Ablation: the ARREST-AF cohort study. Journal of the American College of Cardiology. 2014;64(21):2222–31. DOI: 10.1016/j.jacc.2014.09.028

17. Risom SS, Zwisler A-DO, Rasmussen TB, Sibilitz KL, Svendsen JH, Gluud C et al. The effect of integrated cardiac rehabilitation versus treatment as usual for atrial fibrillation patients treated with ablation: the randomised CopenHeartRFA trial protocol. BMJ Open. 2013;3(2):e002377. DOI: 10.1136/bmjopen-2012-002377

18. Risom SS, Lind J, Dickson VV, Berg SK. Exploring the Mechanism of Effectiveness of a Psychoeducational Intervention in a Rehabilitation Program (CopenHeartRFA) for Patients Treated With Ablation for Atrial Fibrillation: A Mixed Methods Study. Journal of Cardiovascular Nursing. 2019;34(4):336–43. DOI: 10.1097/JCN.0000000000000584

19. Risom SS, Lind J, McCabe P, Berg S. Patient perspectives of participating in the cardiac CopenHeartRFA rehabilitation program for patients treated with ablation for atrial fibrillation. Journal of Multidisciplinary Healthcare. 2018;11:167–74. DOI: 10.2147/JMDH.S152823

20. Bubnova M.G., Aronov D.M. Atrial Fibrillation: the Association with Physical Activity and the Effects of Cardiac Rehabilitation. Rational Pharmacotherapy in Cardiology. 2020;16(5):804–14. DOI: 10.20996/1819-6446-2020-10-21

21. Gessler N, Willems S, Steven D, Aberle J, Akbulak RO, Gosau N et al. Supervised Obesity Reduction Trial for AF ablation patients: results from the SORT-AF trial. EP Europace. 2021;23(10):1548–58. DOI: 10.1093/europace/euab122

22. Parkash R, Wells GA, Sapp JL, Healey JS, Tardif J-C, Greiss I et al. Effect of Aggressive Blood Pressure Control on the Recurrence of Atrial Fibrillation After Catheter Ablation: A Randomized, Open-Label Clinical Trial (SMAC-AF [Substrate Modification With Aggressive Blood Pressure Control]). Circulation. 2017;135(19):1788–98. DOI: 10.1161/CIRCULATIONAHA.116.026230

23. Rienstra M, Lubitz SA, Mahida S, Magnani JW, Fontes JD, Sinner MF et al. Symptoms and Functional Status of Patients With Atrial Fibrillation: State of the Art and Future Research Opportunities. Circulation. 2012;125(23):2933–43. DOI: 10.1161/CIRCULATIONAHA.111.069450

24. Ferre-Vallverdu M, Ligero C, Vidal-Perez R, Martinez-Rubio A, Vinolas X, Alegret JM. Improvement in Atrial Fibrillation-Related Symptoms After Cardioversion: Role of NYHA Functional Class and Maintenance of Sinus Rhythm. Clinical Interventions in Aging. 2021;16:739–45. DOI: 10.2147/CIA.S305619